✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Trident Lifeline Ltd.

TLL

Market Cap
₹292 Cr.
P/E
15.31

Trident Lifeline Ltd.

  • Trident Lifeline
  • Medicamen Biotech
  • Gennex Lab

FAQs on Trident Lifeline Ltd. Shareprice

Trident Lifeline has given better returns compared to its competitors.
Trident Lifeline has grown at ~23.1% over the last 3yrs while peers have grown at a median rate of -17.54%

Trident Lifeline is not expensive.
Latest PE of Trident Lifeline is 15.31, while 3 year average PE is 40.98.
Also latest EV/EBITDA of Trident Lifeline is 17.02 while 3yr average is 33.58.

View FAQ's On Business

Growth Table

  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Balance Sheet

  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Cash Flow

  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Quarterly Results

  • Trident Lifeline Ltd.
  • Medicamen Biotech
  • Gennex Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Trident Lifeline Ltd. Financials

Balance sheet of Trident Lifeline is moderately strong.

Yes, The net debt of Trident Lifeline is increasing.
Latest net debt of Trident Lifeline is ₹68.77 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹49.38 Crs.

Yes, profit is increasing.
The profit of Trident Lifeline is ₹15.08 Crs for TTM, ₹11.75 Crs for Mar 2025 and ₹6.34 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Trident Lifeline latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech